Sensus Healthcare (SRTS) Cash from Operations Growth (1y) (2018 - 2026)
Powered by 
Analysis
Sensus Healthcare (SRTS) Cash from Operations Growth (1y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.04 Bn | 177.44 Bn | 7.27 Bn | 21.54% |
| 2 | Intuitive Surgical | 125.02 Bn | 119.81 Bn | 1.96 Bn | 48.31% |
| 3 | Medtronic | 117.84 Bn | 109.02 Bn | 6.34 Bn | 64.80% |
| 4 | Stryker | 105.50 Bn | 102.02 Bn | 4.50 Bn | 13.50% |
| 5 | Boston Scientific | 66.27 Bn | 65.73 Bn | 3.85 Bn | 14.62% |
| 6 | Edwards Lifesciences | 49.60 Bn | 45.35 Bn | 1.35 Bn | 124.64% |
| 7 | Alcon | 33.70 Bn | 32.24 Bn | 1.68 Bn | 0.99% |
| 8 | Dexcom | 32.06 Bn | 30.11 Bn | 830.00 Mn | -11.16% |
| 9 | Steris | 21.02 Bn | 20.54 Bn | 684.20 Mn | -12.60% |
| 10 | Sensus Healthcare | 51.53 Mn | 36.34 Mn | - | -200.51% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -200.51% |
| Mar 31, 2026 | -40.19% |
| Dec 31, 2025 | -166.87% |
| Sep 30, 2025 | -41.94% |
| Jun 30, 2025 | -26.31% |
| Mar 31, 2025 | 67.30% |
| Dec 31, 2024 | -131.00% |
| Sep 30, 2024 | 794.34% |
| Jun 30, 2024 | 470.08% |
| Mar 31, 2024 | -36.52% |
| Dec 31, 2023 | 126.38% |
| Sep 30, 2023 | -88.13% |
| Jun 30, 2023 | -60.86% |
| Mar 31, 2023 | -294.58% |
| Dec 31, 2022 | -468.15% |
| Sep 30, 2022 | 197.13% |
| Jun 30, 2022 | 39.82% |
| Mar 31, 2022 | 376.41% |
| Dec 31, 2021 | -394.44% |
| Sep 30, 2021 | 147.44% |